There are concerns that genetic editing could lead to attempts to create “designer babies”. Read more at straitstimes.com. Read more at straitstimes.com.
Algolein™ debuts with a high-oleic algal oil under the name Algolein™ TG C18/80 designed without genetic modification using ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
A recent decision of the federal government to ban four transgenic cotton hybrid varieties, as illegal and dangerous to ...
The Infinite Loop by Nebius reports on robots training in California to build colonies on Mars, leveraging AI and autonomy ...
Replimune (REPL) stock crashed 19% after FDA rejected RP1 melanoma treatment for second time, citing trial design issues.
Replimune (REPL) stock plunged 19% after FDA issued second rejection of RP1 melanoma immunotherapy, citing inadequate trial ...
AVAI, BIOA, NAGE, LLY, and NVO Lead a New Wave of Metabolic and Molecular Anti-Aging Therapies Issued on behalf of Avaí Bio, Inc. Companies mentioned in this article: Avaí Bio, Inc. (OTCQB: AVAI), ...
Product from Wockhardt, the last remaining maker of porcine insulin, likely won’t be available for regular sale as patients ...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Cicada was first identified in Africa before making its way across the globe and as of February 2026 ...